CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 8 enrolled
Drug / intervention
Chlorogenic aciddrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02245204
NCT02245204Phase 1Completed

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd·interventional·Posted Sep 19, 2014·Updated Nov 21, 2018

In Brief

A Phase 1 clinical trial evaluating Chlorogenic acid for Advanced Cancer. Completed, enrolled 8 participants across 1 site.

Detailed Summary

The purpose of this study: Determining the Maximum Tolerated Dose (MTD), Dose-Limiting Toxicity (DLT), pharmacokinetics characteristic, and dosage regimen of phase II/III of Chlorogenic acid for injection in the advanced malignant tumor subjects;

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Cancer
CountriesChina

Timeline

Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 19, 2014
Enrollment StartSep 1, 2014
Primary CompletionOct 1, 2016
TodayJul 1, 2026
Enrollment to primary: 2.1 yearsPosted 11.8 years ago

Interventions

Chlorogenic aciddrug

Chlorogenic acid for injection is polyphenols, micromolecular and un-endogenous substance. It might play the role of cancer treatment via balancing tumor micro-environmental immune status according to the stability and rationality of immunodeficiency and endogenous immune material expression around the tumor. Chlorogenic acid for injection is made from chlorogenic acid (purity≥98%) which is extracted from folium cortex eucommiae.Chlorogenic acid and its preparations have not been reported as chemical drug and marketed around the world.